Contact Lenses for Visual Acuity
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a 4-visit, multi-site, prospective, controlled, randomized, single-masked (subjects), two-arm parallel group, bilateral, dispensing clinical trial to compare the performance of the Test lens to the Control lens in terms of safety and efficacy.
Who Is on the Research Team?
Johnson & Johnson Vision Care, Inc. Clinical Trial
Principal Investigator
Johnson & Johnson Vision Care, Inc.
Are You a Good Fit for This Trial?
This trial is for adults aged 40-70 who already wear soft contact lenses in both eyes, need vision correction for both distance and reading (presbyopia), have healthy eyes, and do not have certain eye or health conditions like glaucoma, diabetes, severe dry eye, or recent eye surgery. Pregnant or breastfeeding individuals cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to receive either the Senofilcon A or Nelfilcon A lens for the duration of the study
Follow-up
Participants are monitored for safety and effectiveness after treatment, including slit lamp findings and visual acuity assessments
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two types of daily disposable multifocal contact lenses—ACUVUE OASYS MAX 1-Day Multifocal (Senofilcon A) and DAILIES AquaComfort Plus Multifocal (Nelfilcon A)—to see which works better and is safer. Participants are randomly assigned to one lens type.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Eligible subjects will be randomized to the Senofilcon A Lens for the duration of the study.
Eligible subjects will be randomized to the Nelfilcon A Lens for the duration of the study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johnson & Johnson Vision Care, Inc.
Lead Sponsor
Joaquin Duato
Johnson & Johnson Vision Care, Inc.
Chief Executive Officer since 2022
MBA from ESADE, Master of International Management from Thunderbird School of Global Management
Dr. Jijo James, MD
Johnson & Johnson Vision Care, Inc.
Chief Medical Officer since 2014
MD from St. Johns Medical College, MPH from Columbia University
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.